Tender offer for Recordati; Sobi
CVC and GBL launch tender offer for Recordati; Sobi’s gout drug passes Phase 3 test; Immunovant shares open-label arthritis data; Retro Biosciences gets more money Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene…
Plus, news about Immunovant and Retro Biosciences.
💸 CVC and GBL launch tender offer for Recordati: CVC Capital Partners and Groupe Bruxelles Lambert (GBL), a Belgian investment holding company, launched their cash voluntary tender
Source: Endpoints News